Stoke Therapeutics, Inc. - Common Stock (NQ:STOK)

25.08 -0.54 (-2.11%)

Delayed Quote Updated: 2:29 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Stoke Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stoke Therapeutics Presents New In-Vivo Data That Demonstrated Dose-Related Target Engagement and OPA1 Protein Upregulation in Retinal Tissue Following Administration of STK-002

May 02, 2022

From Stoke Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

April 26, 2022

During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

Via Benzinga

Stoke Therapeutics to Present at The Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Meeting

April 07, 2022

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference

April 05, 2022

From Stoke Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 23, 2022

Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the...

Via Benzinga

Recap: Stoke Therapeutics Q4 Earnings ↗

March 10, 2022

Stoke Therapeutics (NASDAQ:STOK) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Stoke Therapeutics to Participate in the Cowen 42nd Annual Health Care Conference

February 28, 2022

From Stoke Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

February 03, 2022

On Thursday, 105 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows And Highs: Meta Platforms (NASDAQ:FB) was the biggest company on...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022 ↗

January 31, 2022

Upgrades UBS upgraded the previous rating for Align Technology Inc (NASDAQ:ALGN) from Neutral to Buy. For the third quarter, Align Tech had an EPS of $2.87, compared to year-ago...

Via Benzinga

Acadia, Stoke Team Up In $900M+ Deal On RNA Therapies For CNS Disorders ↗

January 10, 2022

Acadia Pharmaceuticals Inc (NASDAQ: ACAD) and Stoke Therapeutics Inc (NASDAQ: STOK) will team up on the treatments in rare genetic neurodevelopmental diseases of...

Via Benzinga

Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases

January 10, 2022

From Acadia Pharmaceuticals Inc.

Via Business Wire

Stoke Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 04, 2022

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome ↗

December 03, 2021

Stoke Therapeutics Inc (NASDAQ: STOK) announced highlights from five presentations related to the ongoing clinical development of STK-001 being made at the American...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 3, 2021 ↗

December 03, 2021

Upgrades Cowen & Co. upgraded the previous rating for Marvell Technology Inc (NASDAQ:

Via Benzinga

Stoke Therapeutics Presents Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome at the American Epilepsy Society (AES) 2021 Annual Meeting

December 03, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

61 Biggest Movers From Yesterday ↗

November 23, 2021

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 22, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 95.32% to $9.61 during Monday's regular session. Trading volume for iSpecimen's stock is 70.9 million as of...

Via Benzinga

40 Stocks Moving In Monday's Mid-Day Session ↗

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

Stoke Therapeutics Announces Presentations from the Company’s Dravet Syndrome Program at the American Epilepsy Society 2021 Annual Meeting

November 19, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates

November 08, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For November 22, 2021 ↗

November 22, 2021

Upgrades According to Evercore ISI Group, the prior rating for Kimco Realty Corp (NYSE:

Via Benzinga

Stoke Therapeutics to Present at Upcoming Investor Conferences in November

November 03, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares moved upwards by 44.73% to $3.58 during Wednesday's regular session. Voyager Therapeutics's stock is trading at a...

Via Benzinga

Stoke Therapeutics to Present at the Cantor Global Healthcare Virtual Conference

September 22, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

Stoke Therapeutics Posts Encouraging Interim Safety Data From Early-Stage Dravet Syndrome Trial ↗

September 21, 2021

Stoke Therapeutics Inc (NASDAQ: STOK) announced interim analysis data from Phase 1/2a MONARCH study of STK-001 in children and adolescents with Dravet syndrome....

Via Benzinga

Stoke Therapeutics Announces Positive Interim Safety, PK and CSF Exposure Data from the Phase 1/2a MONARCH Study of STK-001 in Children and Adolescents with Dravet Syndrome

September 21, 2021

From Stoke Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data ↗

September 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.